InflaRx’s vilobelimab met the bar for futility in a Phase III trial for the rare skin disease pyoderma gangrenosum.

Researchers examined the addition of 3D total-body photography and sequential digital dermoscopy imaging to usual care on outcomes in patients at high risk for melanoma.

Skin tags may be painless and generally harmless, but you should get them checked out. They could be a symptom of something ...